Will Cash Price Transparency Benefit Patients?
This Viewpoint discusses the ways in which cash price transparency might influence patients’ choice of clinician and how this would affect health care costs.
Related Articles
Why 2025 will be a recovery year for providers’ finances
Analysts and industry observers say high labor costs and inflated expenses will continue to create challenges for providers in 2025.
What Is Love Bombing? 7 Signs To Look For
If you think your new relationship is too good to be true, you may need to look for red flags associated with love bombing. This…
Changing Medicare Payment to Strengthen Primary Care | NEJM
CMS has taken steps to recognize the importance of primary care and the time and effort required for care teams to develop long-lasting, trusting relationships…
What I wish I knew in residency about becoming chief resident
Going for a chief resident spot requires taking a fresh look at yourself and your program. AMA member Victoria Gordon, DO, advises what to focus…
Preparing for the Future Demand of Hospital Medicine
Prepare for the future of hospital medicine with insights on workforce trends, growing demands, and strategies to ensure consistent, high-quality care.
Ukraine’s First All-Robot Assault Force Just Won Its First Battle
That Ukraine even needs so many unmanned weapons points to a deep manpower shortage.
Colon Cleansing: What You Should Know
Colon cleansing, sometimes called a colonic or colonic hydrotherapy, is often touted as a treatment for digestive issues. But doctors don’t recommend them. Here’s why.
Italy’s Massive Triple Triplane – Caproni CA.60 Noviplano [Aircraft Overview #13]
The massive Caproni CA.60 was Italy’s first serious attempt at making an aircraft capable of carrying 100 passengers. In fact, in 1921, this was a…
COVID, H5N1 news & more, 12/22/24
As of 12/14/24, wastewater levels of SARS-CoV-2 virus are MODERATE across America with the Midwest now with HIGH levels of COVID in wastewater according to…
Tocilizumab Efficacy in Giant Cell Arteritis Phenotypes | RheumNow
A Spanish Collaborative Group study of Tocilizumab (TCZ) in Giant Cell Arteritis (GCA) demonstrated high efficacy regardless of the different vascular phenotypes treated. Multicentre study of…
